Feb 15 – 19, 2026
Grand Hotel Mediterraneo
Europe/Rome timezone
12th International Conference on Isotopes - 12ICI

PRODUCTION OF Pb-203 AT GIP ARRONAX

Feb 16, 2026, 2:22 PM
2m
Americas Room (Grand Hotel Mediterraneo)

Americas Room

Grand Hotel Mediterraneo

Poster 2. Isotope Applications Poster Session 1

Speaker

Thomas Sounalet (Subatech)

Summary

Lead-212 (T1/2 = 10.6 h) and lead-203 (T1/2 = 51.9 h) can be used as a theranostic pair of isotopes for applications in nuclear medicine. 212Pb is used for α-targeted therapy, while its counterpart 203Pb is suitable for SPECT imaging thanks to its 279.2 keV (80.9%) γ-emission. Currently, 203Pb is produced by irradiating natural Tl, Tl-203 and Tl-205 targets, with protons. In this work, we investigate an alternative production route using 205Tl irradiated with deuterons at GIP Arronax [1] [2].

To prepare enriched Tl-205 targets, we employed an electrodeposition technique using pulse-reverse current onto a gold substrate. Deposition was carried out at 25°C and pH 8, using EDTA as a complexing agent, hydrazine to prevent oxidation, and Brig-35 as a surfactant. A uniform 40 µm deposit with good adhesion was obtained [3]. Separation of Tl and Pb was achieved using Triskem's Pb resin, yielding high-purity Pb-203 in 1 M ammonium acetate solution (pH 5).

Since September 2023, monthly production has been scaled up by increasing the beam intensity (from 50 µA to 70 µA) and irradiation time (from 1 h to 10 h). At Calibration Time (CT, 2 days post-EOB), the radionuclidic purity of Pb-203 exceeded 99.3%, with all impurities below the γ-spectrometry detection limit, except for Pb-201 (< 0.7%). Up to 15 GBq of Pb-203 was obtained at CT. Pb recovery averaged 81 ± 4%, while metallic impurities (Tl, Fe, Ni, Zn, Cu, Hg, and Au) remained below detection limits. Tl recovery consistently exceeded 90%, enabling recycling.

These results demonstrate the feasibility of large-scale production of high-purity Pb-203. Further technical details will be presented in the poster.

[1] F. Haddad et al., “ARRONAX, a high-energy and high-intensity cyclotron for nuclear medicine,” Eur J Nucl Med Mol Imaging, vol. 35, no. 7, pp. 1377–1387, 2008, doi: 10.1007/s00259-008-0802-5.
[2] T. Sounalet et al., “Production of 203Pb from enriched 205Tl using deuteron beams,” Appl Radiat Isot, p. 111190, 2024, doi: 10.1016/j.apradiso.2024.111190.
[3] T. Sounalet et al., “Manufacture of Tl targets by electrodeposition for the study of excitation functions of 203Pb,” EPJ Web Conf., vol. 285, p. 09001, 2023, doi: 10.1051/epjconf/202328509001.

Are you interested/eligible for the Young Session? No, I am not eligible

Author

Thomas Sounalet (Subatech)

Co-authors

Mr Alexandre Rousseau (GIP Arronax) Dr Arnaud Guertin (Subatech) Dr Aurélien Vidal (GIP Arronax) Dr Etienne Nigron (GIP Arronax) Mr Fabien Brelet (GIP Arronax) Prof. Ferid Haddad (Subatech/Arronax) Mrs Héloïse Dufour (GIP Arronax) Mrs Katalin Briand (GIP Arronax) Mrs Kerthana Kamalakannan (GIP Arronax) Mrs Lou Galichet (GIP Arronax) Mrs Maryne Tarinas (GIP Arronax) Mrs Nadia Audouin (GIP Arronax) Mr Nicolas Bozovic (Orano med) Mr Rémy Dureau (Orano med) Mr Simon Tellier (GIP Arronax) Mr Tony Prezeau (GIP Arronax)

Presentation materials

There are no materials yet.